Yu Ma
Impact in
- Cognitive Neuroscience top 5%
- EEG and Brain-Computer Interfaces
- Sleep and Wakefulness Research
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
Papers in
- Neurology 11
- Neurological disorders and treatments 10
- Parkinson's Disease Mechanisms and Treatments 7
- Botulinum Toxin and Related Neurological Disorders 3
-
- Drug-Induced Hepatotoxicity and Protection 4
- Journals
- PLoS ONE (4 papers)Tuberculosis (2 papers)Neuromodulation Technology at the Neural Interface (2 papers)World Neurosurgery (1 paper)Surgery (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yu Ma
48 papers receiving 925 citations
Peers
Comparison fields: 5 of 125
- Cognitive Neuroscience 256
- Infectious Diseases 194
- Pharmacology 90
- Neurology 154
- Neurology 66
Countries citing papers authored by Yu Ma
This map shows the geographic impact of Yu Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Ma more than expected).
Fields of papers citing papers by Yu Ma
This network shows the impact of papers produced by Yu Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Ma. The network helps show where Yu Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 11 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 3 | |
| 8 | 2019 | 25 | |
| 9 | 2018 | 34 | |
| 10 | 2018 | 38 | |
| 11 | 2018 | 9 | |
| 12 | 2013 | 4 | |
| 13 | 2013 | 16 | |
| 14 | 2013 | 7 | |
| 15 | 2011 | 5 | |
| 16 | 2011 | 18 | |
| 17 | 2011 | 23 | |
| 18 | Subthalamic deep brain stimulation in the treatment of secondary dystonia | 2006 | 1 |
| 19 | 2005 | 7 | |
| 20 | 2002 | 39 |
About Yu Ma
Yu Ma is a scholar working on Neurology, Pharmacology, Cognitive Neuroscience, Infectious Diseases and Biological Psychiatry, having authored 50 papers that have together received 956 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (10 papers), Neurological disorders and treatments (10 papers), EEG and Brain-Computer Interfaces (10 papers), Parkinson's Disease Mechanisms and Treatments (7 papers), Mycobacterium research and diagnosis (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Sleep and Wakefulness Research (4 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). The work is most often cited by research in Cognitive Neuroscience (256 citations), Infectious Diseases (194 citations), Pharmacology (90 citations), Neurology (154 citations) and Neurology (66 citations). Yu Ma has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yuanyuan Wang, Yanan Lu, Yuanyuan Wang, Jianguo Zhang, Ming Ge, Kai Zhang, Zhongcheng Wang, Xin Wang, Jing Ding and Yuhao Zhang. Their work appears in journals such as PLoS ONE, Tuberculosis, Neuromodulation Technology at the Neural Interface, World Neurosurgery and Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.